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Esme “Ezzy” Hodge, left, of Bristol, U.K.,
recently took her first independent steps
following selective dorsal rhizotomy (SDR)
surgery at St. Louis Children’s Hospital.
Neurosurgeon T.S. Park, MD, has performed
SDR on more than 3,700 patients with
cerebral palsy worldwide. In most cases, the
procedure permanently removes spasticity,
enabling patients to walk again. See page 24.
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Envisioning cells like little machines,
Farshid Guilak, PhD, is reprogramming
them to fight arthritis. In the lab, his
team successfully has grown a living
human hip ball joint that suppresses
inflammation. See page 12.
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Cancer weapon
Zika virus kills glioblastoma stem cells in early research
B Y TA M A R A B H A N DA R I

W

postdoctoral researcher Zhe Zhu, PhD, of
neuroprogenitor cells, which generate cells
for the growing brain. Zika virus specifically
targets and kills neuroprogenitor cells.
Collaborating with co-senior authors
Diamond and Milan G. Chheda, MD, of
Washington University, and Jeremy N. Rich, MD,
of UC San Diego, Zhu tested whether the virus
could kill stem cells in glioblastomas removed
from patients at diagnosis. They infected tumors
with one of two strains of Zika virus. Both strains
spread through the tumors, killing the cancer
stem cells while largely avoiding other tumor cells.
The findings suggest that Zika infection
and chemotherapy-radiation treatment have
complementary effects. The standard treatment
kills the bulk of the tumor cells but often leaves
the stem cells intact to regenerate the tumor.
Zika virus attacks the stem cells but bypasses
the greater part of the tumor.
To find out whether the virus could help
treat cancer in a living animal, the researchers
injected either Zika virus or salt water (a placebo)
directly into the brain tumors. Tumors were
significantly smaller in the Zika-treated mice
two weeks after injection, and those mice
survived significantly longer.
The idea of someday injecting a virus
notorious for causing brain damage into people’s
brains seems alarming, but Zika may be safer
for use in adults because its primary targets —
neuroprogenitor cells — are rare in the adult brain.
The fetal brain, on the other hand, is loaded with
such cells, which is part of the reason why Zika
infection before birth produces widespread and
severe brain damage.
GETTY IMAGES

hile Zika virus causes devastating
damage to the brains of developing
fetuses, it one day may be an effective
treatment for glioblastoma, a deadly form of
brain cancer. New research from Washington
University School of Medicine and the University
of California San Diego School of Medicine
shows that the virus kills brain cancer
stem cells, the kind of cells that are most
resistant to standard treatments.
“We showed that Zika virus can kill
the kind of glioblastoma cells that tend
to be resistant to current treatments
and lead to death,” said Michael S.
Diamond, MD, PhD, the Herbert
S. Gasser Professor of Medicine
at Washington University and
the study’s co-senior author.
The findings are published
Sept. 5 in The Journal of
Experimental Medicine.
The standard glioblastoma
treatment is aggressive
— surgery, chemotherapy
and radiation — yet most
tumors recur within six
months. A small population
of glioblastoma stem cells
often survives the onslaught
and continues to divide,
producing new tumor cells to
replace the ones killed by the
cancer drugs.
In their neurological origins
and near-limitless ability to create
cells, glioblastoma stem cells reminded
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Q&A
Diamond

Chheda

with Mike Diamond and Milan Chheda

How did you come up with the idea of using
Zika to treat glioblastoma?
Diamond: It was really the idea of Zhe Zhu, who
was a postdoc with Jeremy Rich. He emailed me
several times and said he wanted to do it. I said,
“That’s crazy, I don’t want to do that.” Because
I knew that a related virus — West Nile — had
been tried 50 years ago and it made things worse.
It caused serious brain infections and did not cure
the cancer. So I said, “That’s not going to work.
That’s not safe.” But he kept on asking until I
agreed to let him try. Jeremy sent him over to my
lab for what was supposed to be three months and
turned into a year. And at some point we gathered
enough data to look at which cells were being
infected and found that it was not replicating
throughout the brain and then I no longer had
reservations. After we had established that the
virus could specifically infect the stem cells, we
needed someone with neuro-oncologic expertise.
Milan took on a major role at that point.

What has been the response to the study?

ZHE ZHU

Chheda: We’ve received emails from patients
all over the world. They say that their loved
ones or a friend or they themselves are in this
dire situation and ask if they can try Zika.

We tell them that it’s not FDA-approved, it hasn’t
been proven safe or effective, but some people
say they understand that and they want to try
it anyway. We’ve been asked if we can bring the
virus to some other place, like Mexico, where
FDA rules don’t apply so they can try it. And of
course we can’t do that, but it just goes to show
how desperate people are for any bit of hope.

What do you say to the people who contact you?
Chheda: I ask if they want to speak on the
phone. They tell me about their current treatment
or plans for treatment. The one thing that stands
out is that throughout the world, almost everyone
is treated the same way when they are first
diagnosed. And universally the situation is dire
no matter where you live. I tell them that we’re
working on getting to human trials, but we’re
talking about at least a year and a half before
anything could potentially be tested in humans.

What do you have to do before you can test
it in people?
Diamond: We are trying to get some guidance
on that from the FDA. Because of the dire
nature of the disease, the bar might not be as
high as we thought. The key issue, of course,
is safety. Although discussions are planned,
the FDA likely will require that giving Zika
doesn’t make things worse in mice, and that we
can manufacture the virus according to good
manufacturing practices. But they may want
more, too; it’s not totally clear yet.

From left, brain cancer stem cells before and after Zika
treatment. A new study shows that the virus, known for
killing cells in the brains of developing fetuses, could
be redirected to destroy the kind of brain cancer cells
that are most likely to be resistant to treatment.
4 Washington University School of Medicine
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iteman Cancer Center is one of the
first U.S. centers to offer an immune
therapy targeting advanced nonHodgkin lymphoma (NHL) in adults. Yescarta,
a chimeric antigen receptor (CAR)-T cell
therapy, is the second gene therapy approved
by the Food and Drug Administration
(FDA). Washington University doctors and
researchers were involved in clinical trials
leading to its approval.
In cancer patients, the immune system’s
T cells lose the ability to recognize and attack
cancer cells. CAR-T cell therapy involves
isolating a patient’s T cells from the blood
and genetically altering — or supercharging
— those cells to home in on cancer cells.
Once a CAR-T cell finds its target, it
behaves as any T cell should — triggering a
chain reaction that destroys the cancerous
cell. There is evidence that some CAR-T cells
may maintain active surveillance and ramp
up again in response to cancer recurrence.
CAR-T cells can be programed to lock on to
different cell surface features, suggesting the
strategy could expand to other cancers.

The therapy for NHL is available
only to adult patients whose cancer
has not responded to standard
treatments, including chemotherapy
and bone marrow transplantation. Kite
Pharma developed the new treatment.
Because the therapy induces a
heightened immune response, there
can be a range of side effects, from
fever and shortness of breath to
kidney failure and seizures. Many of
the side effects are manageable, but
some are severe and a few can be
life-threatening, which is why the first centers
selected to administer the new therapy are
those with extensive expertise in treating
blood cancers.
The first cancers to be treated with
CAR-T cell therapy include certain types of
large B-cell lymphomas in adults and acute
lymphoblastic leukemia (ALL) in children.
Clinical trials of CAR-T therapy have shown
what doctors have called remarkable
remission rates among children with ALL
and adults with lymphomas and multiple

SARA MOSER

Immune therapy targets certain blood cancers

T cells are isolated from the blood and modified to
home in on the type of cell affected by the cancer.
myeloma. In patients whose disease has
not responded to standard therapies or has
relapsed, CAR-T therapy has achieved from
40 to 80 percent remission rates. Some patients
have remained in remission for several years.
Doctors at Siteman also are evaluating
or soon will be evaluating CAR-T therapy
via clinical trials for sarcoma, melanoma,
lung and ovarian cancer, leukemia and
multiple myeloma.

Potential new therapy relieves chronic itch

GETTY IMAGES

New research has identified immune signaling molecules that
may underlie chronic itching, an unrelenting urge to scratch.
The researchers also discovered that patients with chronic
idiopathic pruritus, a type of itch from an unknown cause,
improve when given the rheumatoid arthritis drug tofacitinib
(Xeljanz). Earlier attempts to treat their itching with other
anti-inflammatory
drugs had been
unsuccessful. Within
one month of
taking tofacitinib, all
five study patients
experienced marked
relief: They stopped
scratching, started
sleeping again and
returned to more
productive lives.

outlook.wustl.edu

“Obviously, we’ll need to do a larger study, but the early results
are very encouraging,” said Brian S. Kim, MD, an assistant professor
of medicine and co-director of the Center for the Study of Itch.
As part of the study, the researchers showed that the
immune signaling molecule interleukin-4 (IL-4) activates
sensory neurons in mice and people. IL-4 signaling can
jumpstart chronic itching in the setting of inflammation
but also independently of pathways directly linked to
inflammation, they found. Chronic idiopathic pruritus, for
example, isn’t associated with inflammation.
Kim’s team, led by MD/PhD student and first author Landon
K. Oetjen, engineered mice to have sensory neurons that
lacked the ability to respond to IL-4. When exposed to stimuli
that should have made them itch, the mice didn’t scratch.
The researchers then determined that IL-4 stimulates
JAK1, a key protein within nerve cells that may be a uniquely
sensitive target for multiple types of itch. The drug tofacitinib
blocks this protein.

Outlook 5
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cientists working to develop
treatments for neurodegenerative
diseases have been stymied by the
inability to grow human motor neurons in the
lab. Motor neurons drive muscle contractions,
and their damage underlies devastating
diseases such as amyotrophic lateral sclerosis
and spinal muscular atrophy.
Now, School of Medicine scientists have
converted skin cells from healthy adults
directly into motor neurons without going
through a stem cell state.
The technique makes it possible to study
motor neurons of the human central nervous
system in the lab. Unlike commonly studied
mouse motor neurons, human motor neurons
growing in the lab would be a new tool since
researchers can’t take neuron samples from
living people but can easily take skin samples.
Avoiding a stem cell state allows the
resulting motor neurons to retain the age
of the original skin cells and, therefore,
the age of the patient. Maintaining the
chronological age of these cells is vital when
studying neurodegenerative diseases that
develop in people at different ages and
worsen over decades.

“In this study, we only
used skin cells from healthy
adults ranging in age from
early 20s to late 60s,” said
senior author Andrew S. Yoo,
PhD, an assistant professor
of developmental biology.
To convert skin cells
into motor neurons, the
researchers exposed the
skin cells to molecular
signals that are usually
present at high levels in the
brain. Past work by Yoo and
his colleagues — then at
Stanford University — showed that
exposure to two short snippets of RNA,
called miR-9 and miR-124, turned human
skin cells into neurons.
After much experimentation, researchers
found that adding two more signals to the
mix — transcription factors called ISL1 and
LHX3 — turned the skin cells into spinal cord
motor neurons in about 30 days.
The combination of signals tells the cell
to fold up the genetic instructions for making

DANIEL ABERNATHY

Skin cells turned into human motor neurons

Scientists have discovered a new way to convert
human skin cells directly into motor neurons (above).
skin and unfurl the instructions for making
motor neurons.
The researchers said the converted motor
neurons compared favorably to normal mouse
motor neurons. Future work studying neuron
samples donated from patients after death
is required to determine how precisely these
cells mimic native human motor neurons.

Medical students not trained to prescribe marijuana
who earned their medical degrees from schools around the
country. Nearly 90 percent felt they weren’t prepared to
prescribe medical marijuana, and 85 percent said they had not
received any education about the drug during medical school
or residency.
In examining a curriculum database maintained by the
Association of American Medical Colleges, the researchers
found that only 9 percent of medical schools had reported
teaching their students about medical marijuana.
“Medical education needs to catch up to marijuana
legislation,” said senior author Laura Jean Bierut, MD, the
Alumni Endowed Professor of Psychiatry and a member of
the National Advisory Council on Drug Abuse. “Physicians
in training need to know the benefits and drawbacks
associated with medical marijuana so they know when or
if, and to whom, to prescribe the drug.”

GETTY IMAGES

Although 29 states and the District of Columbia allow
marijuana use for medical purposes, few medical students
are being trained how to prescribe the drug, according to
School of Medicine research.
The research team, led by first author Anastasia B.
Evanoff, a third-year medical student, sent surveys to
curriculum deans at 172 medical schools in North America,
including 31 that specialize in osteopathic medicine, and
received 101 replies. Two-thirds reported that their graduates
were not prepared to prescribe medical
marijuana. A quarter of deans said their
trainees weren’t even equipped to answer
questions about medical marijuana.
The researchers also surveyed 258
residents and fellows

6 Washington University School of Medicine
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Algorithm could speed
Parkinson’s diagnosis
Before symptoms become pronounced, there is no reliable
way to identify who is on track to develop Parkinson’s
disease, a debilitating movement disorder.
But School of Medicine researchers have analyzed
Medicare claims data of more than 200,000 people to
develop an algorithm to predict whether a patient one day
will be diagnosed with Parkinson’s. The algorithm relies on
information in patients’ medical records, such as tests and
diagnoses of various medical conditions.
“Using this algorithm, electronic medical records could
be scanned and physicians could be alerted to the potential
that their patients may need to be evaluated for Parkinson’s
disease,” said Brad
A. Racette, MD,
the Robert Allan
Finke Professor
of Neurology
and the study’s
senior author.
“One of the
most interesting
findings is that
people who are
going to develop
Parkinson’s
have medical
histories that are
notably different
from those who
don’t develop the disease. This suggests there are lifelong
differences that may permit identification of those likely
to develop the disease decades before onset.”
The study is available online in the journal Neurology.
Many of the claims codes referred to problems
already known to be associated with Parkinson’s such as
tremors, posture abnormalities, psychiatric or cognitive
dysfunction, gastrointestinal problems, sleep disturbances,
fatigue and trauma, including falls. Other factors
associated with the disease included weight loss and
multiple forms of chronic kidney disease.
In the 18 months before diagnosis, people endured a
flurry of doctor visits and medical tests. Most likely, their
symptoms were worsening, and their doctors were running
test after test, looking for the cause, said Racette. Using
this algorithm potentially could help reduce unnecessary
tests and speed the process of diagnosis, he said.

outlook.wustl.edu

In single-cell RNA sequencing, individual cells are suspended in water
droplets that contain a coated bead. When the cell is purposefully broken
apart, the coated bead captures the cell’s RNA so it can be analyzed. Above,
the large circles are water droplets. Smaller, dark circles are the coated
beads. In the center, a single translucent kidney cell from a mouse touches
one of the beads. Each droplet is about the diameter of a human hair.

Facebook CEO supports
Human Cell Atlas projects
The Chan Zuckerberg Initiative has awarded pilot
grants to two School of Medicine researchers,
supporting projects contributing to the Human Cell
Atlas. This is an international effort to create a detailed
map of all cells in the human body. Charting the
locations of individual cells, unraveling their genetics
and revealing how they interact to regulate health can
shed light on how things go wrong and result in disease.
Facebook co-founder Mark Zuckerberg and his
wife, Priscilla Chan, MD, established the Chan
Zuckerberg Initiative with the goal of eliminating
disease.
Samantha A. Morris, PhD, an assistant professor
of developmental biology and of genetics, and
Benjamin D. Humphreys, MD, PhD, the Joseph
Friedman Associate Professor of Renal Diseases in
Medicine, each have received one year of support to
conduct single-cell RNA sequencing with a focus on
cells in the kidney, liver and small intestine. Their labs
will map out the relationships between and plumb
the biological depths of every one of the millions of
individual cells that make up each of those organs.
Humphreys, a kidney specialist, is investigating why
some patients with diabetes experience kidney failure
quickly while others gradually develop kidney damage.
Morris is focused on cells in the liver and small
intestine. A goal of her research is to engineer
a working intestine as a therapy for short bowel
syndrome. The condition can lead to malnutrition
after a portion of the bowel has been removed, often
to treat conditions such as cancer or Crohn’s disease.
Outlook 7
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Good fat in our bodies helps burn calories, while the bad
fat hoards calories, contributing to weight gain and obesity.
New research has identified a way to convert bad, white fat
into good, brown fat, at least in mice.
White fat stores calories and pads our bellies, hips and
thighs. Brown fat, found near our necks and shoulders,
burns calories through a process that generates heat.
Beige fat — an intermediary between white and brown
fat — was discovered in adult humans in 2015. It functions
more like brown
fat and can protect
against obesity, said
first author Irfan
J. Lodhi, PhD, an
assistant professor
of medicine in
the Division of
Endocrinology,
Metabolism and
Lipid Research.
His team created
White fat cells from a normal mouse, left, and from
a genetic strain of
a mouse lacking the PexRAP protein.
mice that didn’t
make a specific protein called PexRap in white fat cells.
The researchers found that blocking the protein triggered
the white fat to begin to brown into beige fat, causing the
fat cells to burn calories. The mice with more beige fat were
leaner than their littermates, even when they ate the same
amount of food. They also burned more calories.
Lodhi said if PexRAP could be blocked safely in human
white fat cells, people might have an easier time losing weight.

Hultgren elected to National
Academy of Medicine
Scott J. Hultgren, PhD, the Helen
L. Stoever Professor of Molecular
Microbiology, has been elected to the
National Academy of Medicine, a part
of the National Academy of Sciences.
Membership is one of the highest
honors in the field of medicine.
Hultgren has made groundbreakEnjoy
interactive
elements and
ing
contributions
to understanding
added
content
urinary tract
infections.
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Can laughing gas help
prevent suicide?
Researchers are studying the use of nitrous oxide —
laughing gas — as a treatment for patients who are
hospitalized due to suicidal thoughts.
Most standard antidepressant drugs affect norepinephrine
and serotonin receptors in the brain, but can take weeks to
improve a person’s symptoms. Nitrous oxide interacts with a
different type of
receptor in the
brain — NMDA
glutamate
receptors —
sometimes
improving
symptoms
within hours.
“Nitrous
oxide may very
quickly improve
depression in
these patients,”
said Peter
Nagele, MD,
an associate
professor of anesthesiology and of genetics. “The gas has
very few side effects because it leaves the body very quickly
once people stop breathing it. However, it appears from our
previous research that the antidepressant effects of nitrous
oxide may linger in the brain long after the drug is out of
the body.”
In this new study — funded by a grant from the
American Foundation for Suicide Prevention — people who
have attempted suicide will breathe a mixture of oxygen and
nitrous oxide for one hour, every other day, for one week.
Half of the anticipated 50 study patients will receive this
mixture; the other half will receive oxygen — but without
the nitrous oxide — over the same amount of time. All
participants will receive antidepressant drugs or talk therapy
normally prescribed during such a hospitalization.
Ongoing follow-up visits will monitor the participants’
mental state. “If such problems re-emerge, the study is
designed to provide ‘booster’ treatments with nitrous oxide,
which we believe will continue to lower the likelihood of
future suicidal thoughts,” said Charles R. Conway, MD,
a professor of psychiatry.

Winter 2017-18

GETTY IMAGES

Scientists convert bad body fat
in mice into good fat

GETTY IMAGES

Too many brain connections
may be at root of autism

R

odents that lack a gene linked to
autism form too many connections
between neurons and have
difficulty learning, according to a School of
Medicine study. The findings suggest that
some autism symptoms may stem from
miscommunication among brain cells.
“This study raises the possibility that there
may be too many synapses in the brains
of patients with autism,” said senior author
Azad Bonni, MD, PhD, the Edison Professor of
Neuroscience and head of the Department of
Neuroscience. “You might think that having
more synapses would make the brain work
better, but that doesn’t seem to be the case.”
Autism, a neurodevelopmental disorder,
is characterized by social and communication
challenges.
Of the many genes linked to autism, six
are known as ubiquitin ligases because they
attach a molecular tag, called ubiquitin, to
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proteins. These tags function like a work
order, telling the rest of the cell how to deal
with the tagged proteins: This one should
be discarded, that one should be rerouted to
another part of the cell.
Some people with autism carry a mutation
that prevents one of their ubiquitin genes
from working properly. But it is poorly
understood how problems with tagging
proteins affect the brain’s hardwiring and
operation, and why such problems may
lead to autism.
To understand the role of ubiquitin
genes in brain development, Bonni, first
author Pamela Valnegri, PhD, and colleagues
removed the ubiquitin gene RNF8 from
neurons in the cerebellums of young mice.
Neurons without RNF8 formed about
50 percent more functioning synapses — the
connections that allow neurons to send signals
to each other — than those with the gene.

Mutations in a gene linked to autism cause
neurons to form too many connections in
rodents. The findings suggest that malfunctions
in communication between brain cells could be
at the root of autism.

The cerebellum is indispensable for
movement and learning new motor skills.
Some common symptoms of autism —
such as motor incoordination and a tendency
to walk tippy-toed — involve control of
movement.
The animals missing the RNF8 gene
walked normally and appeared coordinated,
but were unable to learn new motor skills.
The researchers since have tested other
autism-associated ubiquitin genes. All of
them led to an increase in synapses when
inhibited, suggesting that too many synapses
could be the reason why these genes are
linked to autism. If this hypothesis proves true
in people, finding ways to control the number
of synapses might benefit those with autism.
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Medical school physicians,
staff aid hurricane victims

Stephen Liang, MD, center foreground, and teammates in Missouri Task Force 1.

STEPHEN LIANG, MD

Assistant professor of medicine and
of emergency medicine
Liang responded to Hurricane Harvey as a member of
Missouri Task Force 1, part of the Federal Emergency
Management Agency’s (FEMA) National Urban Search
& Rescue Response System. As Harvey made landfall in
Houston, FEMA called on Missouri Task Force 1 to deploy a
team specialized in swift-water rescue. The task force rescued
or evacuated about 400 people, as well as many pets. Liang
was principally responsible for keeping the team healthy as it
conducted strenuous operations. He also conducted medical
checks on people brought to safety by his teammates.
10 Washington University School of Medicine

DOUGLAS CHAR, MD

Professor of emergency medicine
A team member with the
National Disaster Medical
System (NDMS), Char
serves as the medical
director of a Missouri
group of more than 100
doctors, nurses, paramedics and other health-care
professionals. During
Hurricane Harvey, Char’s
group was assigned to
Dallas. Later, he traveled
to Austin as chief medical
officer and consultant for a
U.S. Department of Health Douglas Char, MD, in the crisis room.
and Human Services (HHS)
team handling hurricane-related flooding in Texas
and Louisiana. He helped decide which shelters needed
medical services and for how long, and compiled reports
on disease outbreaks. After two weeks, he flew to Washington,
serving as the overnight chief medical officer — dealing with
Hurricanes Harvey, Irma and Maria — in the HHS crisis
room, which is staffed 24 hours a day in national emergencies.
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COURTESY OF DOUGLAS CHAR

COURTESY OF MISSOURI TASK FORCE 1

Washington University faculty and staff helped with emergency relief efforts after devastating
hurricanes hit the southern U.S. and the Caribbean this summer. While they were away, their
colleagues pulled together to keep operations on the Medical Campus running as normal.

COURTESY OF JIM FEHR

Jim Fehr, MD, far right, with physicians and nurses at Pavia Arecibo Hospital.

JIM FEHR, MD
COURTESY OF BOONE COUNTY FIRE PROTECTION DISTRICT

Professor of anesthesiology and of pediatrics

JACOB KEEPERMAN, MD

Assistant professor of anesthesiology
and of emergency medicine
Keeperman serves as a member of the Midwest-1 Disaster
Medical Assistance Team of the NDMS and works part
time for Air Evac Lifeteam, a national helicopter emergency
medical services company. As the Missouri medical director
of an Air Evac operations team, he decides which aircrafts
get sent to affected areas and what protocols will be followed.
After Hurricane Harvey, Air Evac sent 16 aircraft from
throughout the national fleet to Houston. There, team
members delivered patients from flooded hospitals to dry
medical centers, and patients in need of dialysis to dialysis
centers outside of Houston. The company also sent aircraft
to Florida in response to Hurricane Irma.

In hurricane-ravaged Puerto Rico, Fehr’s main job as part of
the federal government’s Disaster Medical Assistance Team
(DMAT) was to deal with nonemergency and logistical needs
so health-care workers on the island commonwealth could
concentrate on providing care to the sickest, most desperate
residents. Fehr’s team, including nurses from Barnes-Jewish
Hospital and St. Louis-area physicians, pharmacists and
paramedics, worked to prevent indirect deaths related to
Hurricane Maria. Indirect deaths include, for example, a
patient who dies because storm-damaged roads prevent her
from refilling a life-saving prescription — or the loss of a
patient who is dependent on a kidney dialysis machine in
the midst of a power outage.
COURTESY OF TY DAVISSON

TY DAVISSON

JOE FOWLER

Director of emergency
management and
business continuity
Davisson, deployed
to Puerto Rico with
NDMS, helped coordinate the federal
government’s response
to Hurricane Maria
from an emergency
Ty Davisson, center, leads a meeting with federal
command center in the
response partners.
San Juan Convention
Center. For three weeks, he managed teams of medical
staff (more than 1,000 people in all), mortuary workers,
and public and behavioral health experts. To ensure an
efficient medical response, each day the team planned,
evaluated and tracked resources, determining where
resources should go the following day.
Air Evac Lifeteam sent a Missouri crew to
Texas following Hurricane Harvey.
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GUILAK LAB, WASHINGTON UNIVERSITY
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Lab-grown
cartilage
Engineered stem cells could revolutionize
arthritis therapy and joint replacement
BY JIM DRYDEN

Stem cells, stained green, grow throughout
the pores of a fabric scaffold, stained red,
that is molded in the shape of a hip joint.
After being treated with chemicals, the cells
turn into cartilage. Eventually, the scaffold
melts away, leaving a living replacement joint.
outlook.wustl.edu

Replacing a human joint is common, artificial and
far from permanent. The procedure involves cutting
into the body to remove living bone and replacing it
with metal and plastic. As these parts typically last
15 to 20 years, a second — riskier — replacement
surgery sometimes is necessary.
However, for a million Americans a year in
agony with knee or hip arthritis, such implants are
welcome. Because once cartilage, the tissue lining and
lubricating joints, wears away, the patient is left with
bone-on-bone pain, swelling, stiffness and disability.
School of Medicine researchers are working on a
radically different way to help people with arthritis:
creating living joint replacements from the patient’s
own cells and then programming those cells to fight
an arthritis recurrence.
Farshid Guilak, PhD, and collaborators have
successfully grown part of a living human hip joint
in the lab and now are testing the methodology in
animals. The development ultimately could transform
how arthritis and some orthopedic conditions are
treated. Moreover, aspects of the research have
implications for a host of other diseases.
Outlook 13
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or Guilak, it all began with envisioning
cells as machines.
“My background is in engineering,
but I’ve always worked on cells,” said Guilak, a
professor of orthopaedic surgery, of developmental
biology and of biomedical engineering. “Cells
are the basis of life, but they also are like little
machines. They have motors. They store things
like computers do, and they can generate forces
and crawl around and pull on things.
“They’re little machines that happen to be
alive, and we thought, ‘Why not treat them like
machines and reprogram them to become what
we want them to be?’ And our first thought was
to make cells into things that can treat diseases
automatically.”
Guilak, also the co-director of the Washington
University Center of Regenerative Medicine and
director of research for Shriners Hospitals for
Children-St. Louis, is working in a field known
as synthetic biology. Combining aspects of
engineering and biology, researchers design
and build new cellular components to do
something different from what they do in nature.
Guilak manufactures cells programmed to
combat arthritis. His lab is one of the few labs in
the world doing this type of work. Until now, most
synthetic biology research has been conducted in
bacteria, which are easier to modify than cells.

“We began to work in mammalian cells, and it
was difficult when we first started, but we got very
lucky because as we were launching this research,
the technique called CRISPR/Cas9 came on the
scene, allowing us to quickly edit the genes in
these cells,” Guilak said.
CRISPR/Cas9 technology enables researchers to
alter DNA sequences and modify gene function.

Regrowing cartilage
Starting this process requires the manufacture
of a basic building material: human cartilage.
First, Guilak’s laboratory acquires stem cells from
skin or subcutaneous body fat via liposuction.
Then, the researchers treat those stem cells with
substances that convert them into particular cell
types. “If you pull those cells out of the body and
give them a very defined set of proteins and genes,
they’ll start to make cartilage or bone or even
muscle,” Guilak said.
In this case, researchers treat the stem cells so
that they grow into cartilage, one of the principal
tissues damaged by arthritis.
But Guilak’s team was not content to use stem
cells of ordinary “intelligence;” the researchers
wanted to make them smarter. Using the gene-editing
tool CRISPR/Cas9, the researchers excised a gene in
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From left, Guilak,
Shannon O’Connor,
an MD/PhD candidate,
and Lara Pferdehirt,
a PhD student, examine
samples from a recent
stem cell study.
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the cells associated with inducing inflammation and
replaced it with a gene that dampens it. They dubbed
these cells as “SMART” (Stem cells Modified for
Autonomous Regenerative Therapy).
Inflammation is associated with all forms of
arthritis and triggers much of its pain and discomfort.
Osteoarthritis is a degenerative, inflammatory
condition caused by wear and tear on specific
joints. Rheumatoid arthritis, an autoimmune
disorder, occurs when the immune system attacks
tissues in joints as if they were foreign invaders.
Through an analysis of arthritic cartilage,
Guilak’s former student Jonathan Brunger,
PhD, found that a particular gene, activated by
inflammation, sparks further inflammation in
response to a molecule called tumor necrosis
factor-alpha (TNF-α). This molecule is primarily
responsible for the inflammatory response in
rheumatoid arthritis. Several available drugs block
the TNF pathway to treat arthritis.
“These drugs work in about half of all patients,”
Guilak said, “but they’re given at high doses
continuously, even though the disease waxes and
wanes. What you really want is something that’s
only given when there is a flare in the disease.”
Such medications reduce inflammation, but also
carry side effects; they can suppress the immune
system, affecting the body’s ability to fight infection.
The gene that Guilak and Brunger inserted into
the cartilage cells is activated only during bouts of
arthritis inflammation, targeting the same pathway
as the drugs Enbrel, Humira and Remicade. “We
can control how a cell reacts to the external signals it
receives,” Guilak said. “We can use CRISPR/Cas9 to
make new logic circuits inside a cell.
“In this case, it’s called a closed feedback loop
because the cell has the capacity to shut down
something that’s happening in its environment.
Instead of encountering an inflammation signal
and amplifying it to get bigger and bigger, which is
what happens in arthritis, now when these SMART
cartilage cells see this inflammatory molecule, they
make the drug inhibitor to block it.”

Treating degenerative joint disease
HEALTHY HIP JOINT

Healthy, smooth cartilage
absorbs energy, bears weight
and lubricates the joints for
easy movement.

ARTHRITIC HIP JOINT

Degenerating cartilage results
in bone-on-bone pain, swelling
and stiffness.

ARTIFICIAL HIP JOINT

An artificial prosthesis eases
pain and restores mobility but
wears out in 15 to 20 years.

LIVING JOINT

Arthritis and beyond
Guilak’s team is working to combat the differing
types of arthritis. Solutions range from a living
joint replacement made with SMART cells for
localized osteoarthritis to a possible implant or
vaccine for the systemic disorder rheumatoid
arthritis. Encased SMART cells could be placed
under the skin the same way Norplant birth-control
outlook.wustl.edu

Resurfacing the joint with newly
grown human cartilage potentially
could last longer with fewer side
effects. Engineered cells could
prevent an arthritis recurrence.

Outlook 15

Rebuilding a human hip
One day, researchers may be able to resurface an arthritic joint
using a patient’s own stem cells.

S MART CEL L S
With gene-editing technology,
the stem cells are rewired to
fight arthritis.

S TE M C EL L S
Stem cells are acquired from
the skin or from subcutaneous
body fat via liposuction.

S C AFFO L D
Cells are placed onto a porous,
woven fabric molded into the
shape of a hip ball. The cells
permeate the fabric as it
melts away.

C ARTI L AG E
Following a chemical
treatment, the cells
change into cartilage.

S YN THE TI C HI P J OI N T
Newly grown cartilage, with
the ability to produce an antiinflammatory drug, could keep
the hip moving for years to come.
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devices deliver hormones to prevent pregnancy for
several months or years at a time. Likewise, because
this strategy heightens immune response, a vaccine
might be an effective biological treatment.
In all of these scenarios, it’s possible, Guilak,
said, that a patient could turn the gene on and off as
needed by taking a pill. The idea is to protect the body
both from inflammation and excessive medication.
One of Guilak’s principal collaborators is
Christine T. Pham, MD, a professor of medicine
who treats patients with rheumatoid arthritis.
Her lab has developed several mouse models of
the disease, allowing researchers to test different
treatment methods.
The researchers also have set their sights well
beyond arthritis. Already, they are thinking about
cellular feedback loops to deliver substances to
fight other disorders, for example, cells that could
be engineered to release insulin in response to
high blood glucose.
For now, however, the primary strategy involves
creating living cartilage from a person’s own stem
cells to ease pain and keep the disorder at bay.

A living prosthesis
Removing a worn-out artificial prosthetic can destroy
the attached bone and put patients at risk for
infection. Because of this, doctors are reluctant
to perform artificial joint replacement in patients
under age 50, leaving children and young adults
with few options. Rising rates of obesity and
arthritis mean that more people in their 40s are
needing hip replacements.
SMART cartilage fashioned in the form of a
living joint potentially could outlast those made of
metal or plastic. Researchers also believe there’s a
lower risk of rejection because the cartilage cells are
taken directly from the patient.
Stem cell treatments for osteoarthritis began as
early as 2008. Mostly, doctors have injected stem
cells directly into affected areas, hoping the cells
would stay in place and turn into cartilage. But this
method has proven unsuccessful, as the cells tend to
float away within a couple of weeks.
Guilak has spent years working on a method
to keep the new cartilage cells in the joint. Before
coming to Washington University, he and his Duke
University colleagues developed a way to weave 600
bio-compatible fibers approved by the U.S. Food
and Drug Administration into a porous, highperformance fabric scaffold.
outlook.wustl.edu

Using MRI images, the researchers can mold
the fabric into the precise shape of a patient’s joint
and seed it with stem cells. “Over a six-week period,
the cells go inside the fabric, start growing, and are
given chemicals that turn them into cartilage cells.
The fabric eventually melts away, leaving a hip made
out of your own cells,” Guilak said. “In the future,
this technique could be used for any joints.”
The weaving pattern makes the implant strong
enough to withstand loads up to 10 times a patient’s
body weight — the standard force during exercise.
Guilak and the other researchers patented the
weaving technique and formed a start-up company,
Cytex Therapeutics Inc.
His laboratory has demonstrated the
technique works in human cells in culture, and
he’s conducting animal studies that look very
promising. As a result, Guilak has won the Arthritis
Foundation’s highest award, and the Proceedings of
the National Academy of Sciences has published the
findings. If those trials remain successful, human
safety studies could begin in three to five years.
Despite worldwide media attention on the
research, Guilak said he is most motivated by his
daily walk to work. “Part of our lab is at Shriners
Hospitals for Children,” he said. “And we see so
many kids come through with difficult problems.
They have a whole lifetime ahead, but almost
everything we do for them is temporary, or it’s
something like a metal-and-plastic implant, which
isn’t a great treatment for a child who will outlast
those implants several times over.
“Seeing those kids is part of what drives us to
find better solutions. Our concept is that we can
make cells that are like tiny computers that sense
what’s causing problems and act accordingly.
“We’re confident we’re on the right track.”

Christine T. Pham, MD, one
of Guilak’s collaborators, is
a professor of medicine who
treats patients with rheumatoid arthritis. Her lab has
developed mouse models
of the disease, allowing
researchers to test different
treatment methods.
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Leading
with

empathy
The transformative influence of a doctor
who hasn’t forgotten his past
BY KRISTINA SAUERWEIN

Will Ross knows he should be dead. Before his teen years,
he had been beaten and bloodied countless times and
stabbed in the arm. He had witnessed an execution-style
murder and had watched riots burn his community.
He had hidden in his house to avoid gangs. Indoors,
he often buried himself in books to escape the alcoholfueled fighting between his mother and her boyfriends.
“We were the poorest of the poor,” Ross said.
“However, my experiences with violence were not
unique. Most of the kids I knew growing up are dead
or in jail. It is not hyperbole to say I should be dead.”
Now an esteemed nephrologist at the School
of Medicine, Ross, MD, MPH, has achieved a level
of success that he had never imagined as a boy
scrounging for food and wearing ill-fitting handme-downs and fearing that rats would crawl over
him in his sleep.
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As part of an orientation
program he designed,
Will Ross, MD, MPH, exposes
first-year medical students
to blighted St. Louis neighborhoods — not unlike the ones
of his own childhood.

outlook.wustl.edu
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R

oss could easily ignore people living
in communities like the ones of his
childhood. But he won’t. His early
experiences inspire him as a physician, a professor
of medicine and as associate dean of diversity.
Long before buzzwords such as “health equity”
emerged in the medical field, Ross was teaching
how health outcomes are compromised by race,
gender, sexual orientation, income, housing,
education and other factors.
Through collaborations with local health
agencies, Ross has initiated dozens of programs
aimed at providing medical care to those who
cannot afford it and at improving community
resources necessary for good health, such as
transportation to a health clinic or access to fresh
fruits and vegetables.
“Humanity is lacking in neighborhoods like
the one I grew up in,” Ross said. “I understand
the social and economic barriers and the anger
rooted in the violence. As physicians, we must
be aware of such obstacles to health care.”

“Humanity is lacking in neighborhoods like the one I grew up in ... .
As physicians, we must be aware
of such obstacles to health care.”
Ross has ingrained these core principles of
understanding and treating underserved patients
into the medical school curriculum. He founded
the Saturday Neighborhood Health Clinic for
the sick and uninsured. More than 90 percent of
Washington University medical students volunteer
and gain practical, hands-on experience at the
federally qualified, no-cost clinic. With faculty
supervision, the students treat about 300 patients
annually for ailments such as diabetes, asthma, high
blood pressure and sexually transmitted diseases.
“Regardless of medical specialty interests, all
students benefit from learning about public health,
and not just from a clinical perspective,” Ross said.
“It teaches compassion and empathy. This is part
of our moral responsibility as a medical school.”
The same year Ross founded the Saturday
Neighborhood Health Clinic — in 1996 — he
also became the associate dean for diversity.
20 Washington University School of Medicine

“Will Ross is empathetic, enthusiastic and
brilliant, and as associate dean for diversity, he
has been nothing short of phenomenal,” said
William Peck, MD, the Alan A. and Edith L. Wolff
Distinguished Professor of Medicine and co-director
of the Center for Health Economics and Policy.
Peck, who served for 14 years as executive
vice chancellor and dean of the medical school,
recruited Ross to the position.
“I knew right away that he was the person for
the job,” Peck said. “Dr. Ross seems laid back,
but he isn’t. He is strategic and determined in his
trailblazing efforts. He has helped to transform
public health care in St. Louis, the state, the country
and the world, all while elevating Washington
University in diversity and medical education.”

Plunging into reality
Ross’s influence on every student is visible
beginning Day One. He created a mandatory,
four-day orientation program for incoming
medical students that includes a diversity
retreat, lectures in health disparities and tours
of St. Louis’ poorest, most racially segregated
nonwhite neighborhoods. Called Washington
University Medical Plunge, the course removes
students from academic and clinical settings
and immerses them into the realities facing
underprivileged patients.
On the tour, students see abandoned and
dilapidated homes, weedy parks where feral dogs
roam and a lack of basic services such as markets
with healthy food.
“It defines the abstract,” Ross said. “There’s no
sugar-coating. Some of the students have never
witnessed poverty before the tour. It’s important
to broaden their outlook because they may one
day treat patients in similar circumstances.”
The tour leaves many students teary-eyed and
emotionally altered. “It had a major impact on me
professionally,” said surgical resident Leisha Elmore,
MD ’13, MPHS. “I found my love for serving
underprivileged communities because of Dr. Ross.”
Similarly, many Washington University students
have said they chose the School of Medicine
specifically because of Ross, who is known for
keeping his office door open and spontaneously
inviting them to his house, where he and nurse
anesthetist Arlene Moore, his wife of nearly
30 years, raised two daughters. Both daughters
are now adults dedicated to social justice.
Winter 2017-18
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Ross is noted for his calm demeanor and dapper
clothing choices. He received his first bowtie for
Easter when he was 4 years old. It’s a fond memory
that has contributed to a collection of 50 bowties.
At first glance, Ayodamola Otun, a first-year
medical student from Nigeria, said he wondered if
the distinguished professor with the bowtie would
have time for him. “I thought Dr. Ross wouldn’t be
interested in me because he had lived in privilege
long enough to forget about people like me. But
I shared my personal challenges.
“It is hard to explain but the way he listened
and responded showed me he cared. I felt safe
and reassured that he was the right mentor, and
Washington University was the right place,” he said.
Ross’s drive to improve medicine for the poor
extends beyond his leadership in St. Louis. He
has assisted in establishing health-care programs
in Ethiopia and South Africa. Currently, in
Haiti, Ross is helping to develop a university
undergraduate program in public health. In the
U.S., he has worked with the Centers for Disease
Control and Prevention and other agencies to
promote cultural awareness among physicians and
reduce minority obstacles to health care. Through
the Association of American Medical Colleges
(AAMC), Ross advocates for increased diversity
among faculty and students.
“Dr. Ross’s work sits at the nexus of academic
medicine and public health,” said Juan Amador,
outlook.wustl.edu

the AAMC’s director of constituent engagement.
“He is a national leader in this area.”
A 2016 AAMC report attributed at least 40
percent of negative patient outcomes to health
disparities caused by social and economic factors.
Such inequities, the report stated, may cause
“systematic, measurable and avoidable health
differences between populations that stem from
social factors such as racism, poverty, lack of
healthful food, and homophobia that result in
disproportionate disease and death for the poor,
racial and ethnic minorities, persons living with
disabilities, LGBT communities and others.”
“Will Ross spoke about these issues when I first
met him decades ago,” said William Danforth,
chancellor of Washington University from 1971
to 1995. “He was compassionate and authoritative,
and I remember thinking, ‘Gosh, that young man
really knows what he’s talking about.’ ”

Ross often hosts dinner and
impromptu gatherings for
students at his Central West
End home.

Hiding from the violence
Ross knows because he lived it. Rarely has he
spoken publically about his traumatic childhood.
However, he has decided to share his experiences,
hoping others will be inspired to persevere to
achieve their goals.
Ross’s journey began in a shotgun shack
with four older siblings, his grandmother and
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Standing before a memorial plaque, new medical
students process the story of how 10-year-old
Rodney McAllister was killed by a pack of stray dogs
in a St. Louis park. The stop was part of a weeklong
orientation focused on health disparities.
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his mother in the small, segregated town
of Helena, Ark. “I was born into a traumatic
situation,” Ross recalled. “My mother’s boyfriend
didn’t like me. My mother had mental health
issues and was not there for me. I never knew
my father. However, my grandmother, Willie
Page, loved me unconditionally and, without
doubt, was the biggest influence of my life.”
As a toddler, Ross’s family moved 90 miles
north to Memphis to hide from his mother’s
abusive boyfriend.
“My first memories were of violence,” Ross said.
“I remember watching people hurt each other and
not knowing what to say or how to process it.”
He aimed for inconspicuousness to avoid
violent interactions. But he was lanky and wore
big glasses, and his awkwardness and vulnerability
grabbed attention. Ross fell prey to the older kids
who assaulted him with rocks and bottles.
He devoured books from the library. He
relished mathematical equations like other kids
enjoyed sports. In kindergarten, he had his first
memorable experience with medicine.
Ross’s sister, Helen, 6, had severe asthma
exacerbated by their mother’s cigarettes. One
night when the siblings were unsupervised,
Helen could barely breathe. Ross and his other
sister, Sherry, 8, helped walk Helen four blocks to
an emergency room. Once they arrived, healthcare workers groused, glared and ignored them.
“Will someone please take care of my sister?”
the young Will Ross demanded. “She can’t breathe.”
“If you don’t like it,” a physician told the
children, “leave.”
They didn’t, and eventually Helen was treated.
But Ross never forgot the experience.
“I was 5 years old and as serious as I’ve ever been,”
Ross said. “I told myself that if I ever became a
doctor, I would never treat a patient so unkindly
and disrespectfully as the staff had treated us.
We were kids. We didn’t want Helen to die.”
Collectively, Ross’s neighborhood experienced
its lowest point on April 4, 1968. For months prior,
African-American sanitation workers had been on
strike to protest economic and social injustices.
Trash overflowed into the streets. An odor of
human waste and rotten food prevailed. Flies
buzzed in swarms.
“Still, we had glimmers of hope,” Ross said.
That’s because Martin Luther King Jr. had
come to Memphis to support the sanitation
workers. “He spoke of civil rights,” Ross said.
“He was leading us toward a better life.”
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A safe passage
Ross’s future shifted one afternoon. With blood on
his shirt — a result of a beating by gang members —
he visited the high school guidance counselor.
The counselor pointed Ross toward Shirley and
Alfred Wexner, who had established a scholarship
fund in their deceased daughter’s honor for
underprivileged kids with academic promise.
Shirley Wexner helped Ross attend a summer
program at Phillips Exeter Academy, an elite
boarding school in New Hampshire. This exposed
him to higher-level coursework and opportunities
at elite colleges. Ross lived with the Wexners
periodically in Memphis, usually during the
harshest moments at his home.
“The Wexner family offered me a safe passage,”
Ross said. “In all likelihood, I would be dead if the
Wexners hadn’t intervened.”
Like many students in the Exeter program, Ross
was accepted into top-tier universities. He received
a full-ride scholarship to Yale University, where
he earned a degree in biology in 1980, and then to
Washington University, where he earned a medical
degree in 1984.
Throughout, the Wexner family provided
financial and emotional support. “We love him,”
said Shirley Wexner’s daughter, Barrie, who
is slightly older than Ross. “We are proud he
continues to help people in need.”

outlook.wustl.edu

Encounters with racism
Despite the Wexners’ support, Ross had to overcome
race-based obstacles. As a second-year medical
student, Ross was interrogated, handcuffed and
thrashed against a car hood. Police believed he
had robbed a store for no reason other than his
skin color. An hour later, Ross was released when
a white classmate vouched that he had been in
class when the robbery occurred.
The incident that most stands out occurred in
1985, when Ross was an internal medicine resident
at a hospital affiliated with Vanderbilt University
in Nashville.
“Around 2 a.m., a middle-age white man came
into the emergency room with an inflamed knee,”
Ross recalled. “I told him I needed to drain the pus.
He said he refused to be treated by a ‘nigger doctor.’
Those were his words. I took a deep breath and told
myself to rise above and take the moral high ground.
“I said, ‘Sir, my name is Dr. Ross. I’m your
doctor. I’m not a nigger. I will be the person who
treats you. But first, you owe me an apology.’ ”
The man apologized. In the years ahead, Ross
would stand up to countless more racist acts.
“I feel there aren’t that many ‘bad’ people;
rather, there are those who have been socialized to
think or act a certain way,” Ross said. “Speaking
out and showing them the damage done by their
sometimes unintentional words or deeds can be
insightful and even therapeutic, as they realize all
of us have unconscious biases.”
Ross continued: “As associate dean for diversity,
I feel I should give voice to those who feel dispossessed
but are either afraid to speak out or don’t know how.
“By speaking out, we improve health care and
we uplift humanity.”

In his nephrology
practice, Ross makes
a concerted effort to
connect with patients
and understand what’s
going on in their lives.
TIM PARKER

However, shortly after 6 p.m., avowed racist
James Earl Ray assassinated King at the Lorraine
Motel, two blocks from Ross’s neighborhood.
“I remember my mother crying, neighbors
crying,” Ross said. “I was shattered. We all were.”
For many, grief turned to anger. “Some people
were armed and rioting,” he said. “They began
destroying non-black businesses. They burned down
our neighborhood market run by Chinese-American
immigrants. Their daughter, Shirley, was my friend.
We did mathematical equations at the store. After
the market was destroyed, I never saw her again.
I have no idea what happened to the family.”
Ross sighed heavily, gazed at the ground and
shook his head in disappointment. “Another
tragic outcome is that the neighborhood never
recovered,” he said. “To this day, it still looks
bombed out.”
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‘Future we only
dreamed of’
A renowned surgeon is restoring
mobility in children with cerebral palsy
BY GAIA REMEROWSKI

Esme “Ezzy” Hodge and her
parents traveled from Bristol,
U.K., for selective dorsal
rhizotomy surgery with
neurosurgeon T.S. Park, MD.

outlook.wustl.edu

As a baby, Alexa Reed seemed to be hitting all her
developmental milestones. When it came time to
walk, however, she started having trouble. Her right
foot turned inward and she had a tendency to rise
up on her tiptoes.
“For two years I asked her pediatrician if this was
normal and if I should do something to fix it,” said
Amy, Alexa’s mom. “We were told that she would
grow out of it and that no intervention was needed
aside from reminding her to walk flat-footed.”
Over time, Alexa’s muscles got tighter, she fell
down frequently and increasingly relied on toewalking. Wearing braces for several years and
undergoing weekly physical therapy to stretch her
tight legs did not improve the situation.
At nearly 4 years of age, Alexa finally received
a definitive diagnosis: spastic diplegic cerebral palsy
(CP), a chronic neuromuscular disorder that causes
tightness and spasms in the extremities. Most commonly
caused by lack of oxygen and early damage to the
brain, spastic CP accounts for almost 80 percent of
CP cases.
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S

oon after Alexa’s diagnosis, the Reeds moved
from Los Angeles to St. Louis for a new job
and to be closer to family — not realizing
that Washington University Medical Campus
is home to T.S. Park, MD, a world-renowned,
uniquely qualified pediatric neurosurgeon who
specializes in treating spastic CP.
Post-surgery, Alexa, now 9, has full function
and enjoys hiking, soccer and hanging out with
friends. In Alexa and in thousands of other kids
worldwide, Park has restored the ability to walk.

Not your average neurosurgeon
Park, the Shi H. Huang professor of neurosurgery, is a pioneer in the use of selective dorsal
rhizotomy (SDR), a spinal surgery that he performs
at St. Louis Children’s Hospital. In the procedure,
Park severs the nerves that cause spasticity.
Park has been performing SDR for 30 years,
treating more than 3,700 patients from 47 states
and 73 countries. Of those cases, only nine have
ever required readmission (four for wound
infections, five with spinal fluid leaks).
Amy found out about Park from an in-home
physical therapist.

Post-surgery, Alexa
Reed, 9, of St. Louis,
has regained full
function.

“It was glaringly clear that our move from
Los Angeles back home to St. Louis was somewhat
serendipitous,” Amy said. “We were exactly where we
needed to be to have the most skilled and successful
surgeon on the planet be the one to end the grasp
that spasticity had on our daughter for good, and
give her a future we had only dreamed of.”
Born in Bristol, U.K., Esme, or Ezzy (as she
likes to be called) Hodge, had to come a bit
farther for help. Ezzy’s parents noticed their baby
daughter wouldn’t reach up for a cuddle and had
trouble balancing independently. An MRI at age
2 revealed Ezzy had suffered a brain injury during
birth. Like Alexa, she was diagnosed with spastic
diplegic CP.
“We were told she would never walk,” said Ezzy’s
mom, Angela. “As parents we were truly devastated.”
Angela found Park’s name during an online
search for potential treatments. “I knew then
I would do whatever it took to get Ezzy this
amazing surgery and prayed Dr. Park would say
yes to helping our little girl, as he was her only
chance,” Angela said.
In the initial patient evaluation, Park’s team tells
the family what type of outcome to expect: Will
the child walk independently, or with crutches or a
walker? Will the child be able to run and jump?
“I’m fairly sure we are the only ones who can
give such a precise prediction,” Park said. “Our
prediction rate is very high — 85 percent correct.”

Constantly seeking
improvements
Severing spinal nerves that cause spasticity has been
going on since the 1900s. But SDR did not make its
way to the U.S. until 1986. Once Park learned about
it in 1987, he began using the technique. By 1991,
he made some key improvements.
The procedure originally involved cutting
through five to six vertebrae in the lower spine to
access the nerves causing spasticity. Park refined
the process so he only needed to cut one lower
vertebra. This less invasive method causes no longterm spinal problems and allows Park to perform
the surgery on children as young as 2, who heal
quickly, as well as patients as old as 50, whose
spines would otherwise never heal completely.
Though Park performs the bulk of SDR
surgeries on children, he also has operated on 130
adults — more than any other doctor in the world
— at Barnes-Jewish Hospital.
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Park celebrates with a gathering of
former patients in the U.K. Patient
families in other countries often throw
welcome parties for Park whenever he
visits to perform consults.

Neurosurgeons from across the globe come
to observe his surgical methods and techniques.
And Park trains fellows at Children’s Hospital in
the procedure.
Park also has published nearly 40 papers about
the surgery in scientific journals. Because his team
is the only one that has performed SDR surgery
for three decades, it is in a unique position to
study long-term outcomes.
Just this year, Park and his colleagues
published two papers: In one, they followed
95 patients between the ages of 23 and 37 who
had SDR surgery 20 to 28 years ago, and, in
another, they surveyed 294 adult patients who
had received SDR surgery as children. Both
studies showed overwhelmingly positive results.
The improvements these patients experienced in
walking and in general quality of life after SDR
surgery extended through adulthood and they
reported no long-term side effects.
“We can clearly say SDR surgery is the only
treatment that can remove spasticity permanently.
No other treatment can do this,” Park said.
“He developed — really single-handedly —
the operation of selective dorsal rhizotomy for
cerebral palsy,” said Ralph Dacey, MD, the chair
of neurologic surgery, in a 2017 tribute video
honoring Park. “And not only did he develop
the processes around doing that procedure very
effectively and safely, but he was able to prove its
efficacy in a series of papers that have become
landmark studies.”
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Results “like magic”
The SDR surgery typically lasts three to four hours,
followed by a five-day hospital stay. Then, the
tough rehabilitation work begins. This includes
daily physical therapy with Children’s Hospital
therapists. Out-of-country patients like Ezzy are
expected to stay in St. Louis for about a month
and then they must continue intensive physical
therapy at home for a few more months while
Park follows the progress remotely.
Ezzy’s improvements began almost
immediately after surgery.
“Like magic before our eyes, she made daily
improvements,” Angela said this past October.
“In just two short weeks, she has managed to
walk with a cane, something I wouldn’t have
believed unless I saw it with my own eyes.”
Some children, such as Alexa, need an additional
orthopedic surgery to lengthen their muscles and/
or tendons, which shorten from prolonged disuse.
Park refers these patients to pediatric
orthopedic surgeon Matthew Dobbs, MD, who
has developed a minimally invasive muscleand tendon-lengthening surgery that further
improves patients’ range of motion and mobility.
The combined surgeries offer dramatic
improvements in patients with severely impaired
mobility, Park said.
Five months post-op, Alexa started playing sports
like soccer and even participated in a 5K race.

Among the many patient
tributes to Park: (top) a
children’s book titled
“Sir Dr. Park and the Dragon,
Spasticity” and (bottom)
a doll made in his likeness.
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Nine months after Alexa’s surgery, Amy reported:
“Dr. Park joyfully told my daughter, ‘You never
have to see my face again!’ She was released from
physical therapy and allowed to simply be a kid.”

A global impact
To help spread the word about the life-changing
surgery, in 2010, Park and his team started the
Selective Dorsal Rhizotomy-St. Louis Children’s
Hospital Facebook page. It has since amassed 9,000
followers. Before long, family-run Facebook pages
championing Park’s expertise began cropping up
— in Brazil, Korea and dozens of other countries.
Park checks the Children’s Hospital and
country-specific Facebook pages multiple times
a day, replying to questions, posting comments,

Luke
Ireland
2015

medical literature and information to help parents
and patients navigate the complex world of CP.
Park dedicates time every year to travel the
world and examine children with CP to see
whether they qualify for SDR surgery. To consult
with these patients, he visits hospitals, clinics,
sometimes even hotels, like the one owned by his
brother in Korea.
Park also tirelessly advocates for health
insurance policies to cover the surgery. He’s given
talks, for example, in Hungary to the country’s
national health insurance program director, and
even testified to a British parliament member.
To help make the surgery financially accessible,
especially for international families, Park lobbied
Children’s Hospital to set a fixed rate of $40,000
for any patient paying out of pocket. Because of
his undeniably positive outcomes, the hospital
agreed. While many families must spend months

Dylan
Singapore
2013

Mikaela
USA
2017
Preston
USA
2017

Surgery patients from
around the world
Park has performed selective dorsal rhizotomy on more than
3,700 patients from 47 states and 73 countries. In most cases,
the procedure permanently removes spasticity, enabling the
patient to walk again and resume age-appropriate activities.
As a result, patient families continually send Park photos
documenting the progress. Pictured above: former patients,
their home country and year of surgery.
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or years fundraising for the surgery, this fixed
rate provides peace of mind. Park does his part by
charging only $100 for initial consults and nothing
for follow-up visits.
Motivated by his international patient base,
Park also worked to improve the hospital’s
interpreter service — something that benefits
every non-English-speaking patient who comes
through the doors.

Beyond grateful
“At the end of the day I know T.S. Park is what we
call a guardian of childhood,” said Joan Magruder,
St. Louis Children’s Hospital president, in a 2017
tribute video honoring Park. “He has done
everything imaginable to make sure that every

child has the opportunity to be a child and to
live their childhood to the absolute maximum.”
This year, Missouri Gov. Eric Greitens and
St. Louis Mayor Lyda Krewson declared Sept. 9
as Dr. T.S. Park Day. The day was marked by a
symposium in Park’s honor.
Families from every corner of the globe make
videos showing their children’s growth and
progress and regularly post them on the SDR
Facebook page — something Park said he loves to
see. “I’ve befriended a number of parents,” Park
said. “We have personally become very connected.”
It’s a bond that Amy, and thousands of
parents like her, acknowledge with gratitude.
“The possibilities for Alexa are endless now,”
Amy said. “My daughter will live a full healthy
life, free from spasticity, thanks to Dr. Park.
He is our hero and will be family to us for life.”

Seth
USA
2009

Sara
Hungary
2011

Matthew
Australia
2013
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Giovana
Brazil
2009
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Personalizing medicine
$10 million gift drives
genome engineering
into therapeutic realm

A

$10 million gift from longtime benefactors George
and Debra Couch is supporting one of the School
of Medicine’s highest priorities: research advances in

personalized medicine. In recognition of the couple’s pledge,
the university has named the newest research building on
the medical school campus — a six-story facility located at
4515 McKinley Avenue — the Debra and George W. Couch III
Biomedical Research Building. The couple was honored during
an Oct. 6 dedication ceremony.
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The gift establishes an endowed fund dedicated to
initiatives aimed at revolutionizing the way disease is
diagnosed, treated and prevented. Because personalized
therapies often are rooted in a person’s genetic makeup, the
new fund provides support for the Genome Engineering
Center (GEC). With the center’s expertise in the latest
genome-editing technologies, such as the ability to reprogram
stem cells, university scientists are able to create precise
cellular models of disease.
“We are deeply grateful to Debra and George Couch
for their extraordinary generosity and for their commitment
to improving human health,” said Chancellor Mark S.
Wrighton. “Their gift will support cutting-edge research
by our talented faculty in pursuit of personalized medical
solutions for patients. With this generous support, the
Genome Engineering Center will be even better positioned
as a resource for our investigators, who are working at the
forefront of the biomedical sciences.”
For the past 11 years, Couch has served on Washington
University’s Board of Trustees. He also has served as a
member of the School of Medicine National Council
for nearly two decades — giving him a close-up view of
breakthroughs that have transformed the way scientists
and physicians approach disease, from the sequencing of
the human genome to research illuminating the key roles
of the immune system and the gut microbiome in conditions
such as cancer, obesity and malnutrition.
“It has been a privilege to be associated with the national
council and be exposed to renowned faculty members
who are making such a difference in the health of people
around the world,” he noted. “As my wife, Debra, and
I began to think about our own legacy, we knew we
wanted to help advance their work.”

Powerful technology
Jeffrey D. Milbrandt, MD ’78, PhD, the James S. McDonnell
Professor of Genetics and head of the McDonnell Department
of Genetics, established the Genome Engineering Center
in 2013. This gift will help advance the center’s innovative
research and support services, particularly providing
investigators with the ability to leverage a powerful DNA
editing tool known as CRISPR-Cas9.
Developed only five years ago, CRISPR-Cas9 is
revolutionizing biomedical research. “The technique allows
us to edit genomes in a very precise way,” Milbrandt said.
“You use a computer to identify the exact DNA stretch
you want to alter and then execute the change rapidly
and efficiently. And you can use the same toolkit on
any organism.”
GEC experts employ CRISPR-Cas9 and other geneediting techniques to create cells and cell lines with
specific mutations and generate libraries of mutations
outlook.wustl.edu

(Top) Chancellor Mark S. Wrighton delivered remarks at the dedication
ceremony for the newly named Debra and George W. Couch III Biomedical
Research Building. (Middle) A portrait of Debra and George Couch will
hang in the building. (Bottom from left) Craig Schnuck, chair of the
Washington University Board of Trustees; Wrighton; Debra Couch;
George Couch; David Perlmutter, executive vice chancellor for medical
affairs and dean of the School of Medicine; and Jeffrey Milbrandt, head
of the McDonnell Department of Genetics, cut the ribbon.
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that help investigators study disease processes, identify
drug targets and advance new treatments.
The center also provides expertise in the manufacturing
of induced pluripotent stem cells (iPSC). These are cells
taken from skin, urine or blood and regressed back into stem
cells. From there, they can be made into nearly any cell type.
When taken from a person with a particular disease, these
converted cells still model the disease process. This opens
up new research opportunities, particularly in previously
inaccessible cell types, such as neurons.
“The gift will serve as a catalyst for developing biological
systems that model diseases in a highly personalized way
and for facilitating the development of new diagnostics and
therapeutics from biologically validated data — our best hope
for discovering precise ways to alleviate human suffering,”
said David H. Perlmutter, MD, executive vice chancellor for
medical affairs and dean of the School of Medicine.
The GEC is a world leader in the production of
engineered cells and cell lines. Since its inception, the
center has created more than 300 CRISPR-modified cell
lines, including more than 100 derived from iPSCs.
The center has provided services to 200 laboratories at
Washington University and about 70 academic institutions
and corporations around the globe. The center helps to
catalyze the work of university researchers who do not have
access to this groundbreaking technology in their own labs.
With a thriving GEC as a resource, researchers can better
compete for federal grant funding and departments can
attract and retain top faculty.
According to Milbrandt, genome engineering and
iPSC technologies are developing at breakneck speed.
“To keep pace, we must constantly invest in research

and development,” he said. “This endowment will allow
us to implement new techniques, invest in highly skilled
personnel, and purchase equipment that will help us move
genome editing into the therapeutic realm.”
In addition to the GEC and the Department of Genetics,
the Couch Biomedical Research Building is home to
numerous initiatives and centers, including the Edison
Family Center for Genome Sciences and Systems Biology,
the Center for Cellular Imaging, the Center for Multiple
Myeloma Nanotherapy, the Optical Radiology Lab, and the
Molecular Imaging Center, and includes research space for
the Center of Regenerative Medicine and the departments
of Medicine and Radiology.

Inspired to help others
For more than three decades, the Couch family has provided
significant support to Washington University. George Couch
attended high school in St. Louis before earning a bachelor’s
degree in economics from Stanford University and a master’s
degree in business administration from Harvard University.
He is founder, chairman, president and chief executive officer
of Couch Distributing Company in Watsonville, California,
and his wife, Debra, owns the Debra C clothing boutique in
Carmel, California.
The family’s commitment to the school began in 1986
with a very personal motivation — the endowment of the
Gregory B. Couch Professorship in Psychiatry in memory
of George’s brother, who developed schizophrenia in his
teens before dying unexpectedly from a heart attack at age
31. A Washington University psychiatrist treated Gregory
while the family was living in St. Louis.
“Gregory was a wonderful person,” George Couch
said. “His dream had been to attend medical school
and become a doctor, so my family decided to endow a
professorship in his memory at the School of Medicine.”
Deanna Barch, PhD, a renowned scientist who
studies cognitive and language deficits in disorders
such as schizophrenia, holds the professorship.
With the endowed fund in personalized medicine,
the Couches saw a unique opportunity to help
advance the quality of life for people around the
globe by contributing to the next phase of discovery.
“If we are able to help mitigate suffering in
any way, that’s a larger contribution to humanity
than Debra and I ever envisioned we would have,”
George said. “We feel very fortunate that we can do
something that has such potential to help others.”
Information for this story was provided by Mary Lee,
Julia Evangelou Strait and Channing Suhl.

George Couch takes a tour of the research building.
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Find your friends.
Classnotes are organized first by
year of degree/training completion
and then in alphabetical order.

How about you?
Share your news via the online
form at wumcnews.org/classnotes.
Submissions will be printed in
a subsequent issue of Outlook
magazine as space allows. Photos
are welcome.

1950 S
Wolff Kirsch, LA ’51,
MD ’55, HS, serves
as director of the
Neurosurgery Center
for Research, Training,
and Education at Loma
Linda University in
California. Loma Linda
University Health honored Kirsch with
the Distinguished Investigator Award in
May 2017. His career accomplishments
include: obtaining more than $10 million in
research grants and more than 40 U.S. and
international patents, identifying two new
amino acids in nature, publishing 200-plus
papers and mentoring many graduate and
medical students.

1960 S
Paula Clayton, MD ’60, recently moved to
St. Louis City and is living within walking
distance of the medical school, where she
hopes to volunteer during the academic year.
Ira J. Kodner, LA ’63,
MD ’67, was chosen
by the St. Andrew’s
Charitable Foundation
as a 2017 Ageless
Remarkable Saint
Louisan. These awards
honor older adults
outlook.wustl.edu

who remain an active force in the St. Louis
metropolitan area and recognize the continued
achievements of those who have made and
continue to make a difference in lives.
Hunter Heath, MD ’68, volunteers one day
per week at Indiana University School of
Medicine, and recently began volunteering
as a workforce development consultant
and adviser/editor on grant submissions
for Fathers and Families Center, a nonprofit
agency in Indianapolis, Ind. Fathers and
Families seeks to reconnect a generation
of young men with the tradition of
responsible fatherhood through assistance
in finishing high school or trade school,
earning and keeping employment, and
more. In his spare time, Heath enjoys
learning how to play the guitar.

1970 S
James M. Mick, MD ’70, retired nearly four
years ago, though he still enjoys serving
as the medical director of the Partners
for Healthy Students program at Yavapai
Regional Medical Center in Prescott, Ariz.
He recently traveled to Spain with his wife,
Francine, and classmate Francisco “Paco” J.
Garriga, MD ’70, and reports that all had a
great time. Mick enjoys spending time in
church activities and with his family.
Timothy J. Ley, MD ’78, HS, a leukemia
researcher and hematologist at WUSM,
has received a seven-year, $6.4 million

Outstanding Investigator Award from the
National Cancer Institute of the National
Institutes of Health (NIH).

1980 S
Jack Turman, PT ’84, was excited to join
the faculty at Indiana University’s Richard
M. Fairbanks School of Public Health as a
professor in the Department of Social and
Behavioral Sciences. Turman is dedicated to
research, teaching and outreach to improve
birth and infant development outcomes in
local and global communities.
Bruce Alter, PT ’86, was awarded
Therapist of the Year at the annual Therapy
in Educational Settings Conference in April
2017 from the Douglas Education Service
District in Eugene, Ore.
Christine Kushner, PT ’87, of Homer Glen,
Ill., proudly announced that her daughter
was accepted into the Program in Physical
Therapy at Washington University.

1990 S
Angela L. Brown, MD ’92, a hypertension
management specialist within the WUSM
Cardiovascular Division, was selected to
receive the 2017 Hugh D. McCulloch Award
from the Greater St. Louis Division of the
American Heart Association.

Barber tributes father

J

ohn C. Barber, MD ’65, of Pittsburgh, Pa., released a
new book, “The One-Eyed Surgeon With Only One
Thumb: Adventures With My Dad, Harry C. Barber, MD,
FACS,” in which he recounts how his father lost a thumb
and one eye in a hunting accident at age 17, but persevered to graduate from the School of Medicine and
have a successful career as a surgeon. Harry Barber also
spent two years in the Arctic Circle during World War II
repairing injured soldiers’ injuries before returning
home to Bloomington-Normal, Illinois. Harry Barber
practiced during an era of $5 office visits and $8 house
calls — although he was quick to reduce his fees and
care for the indigent.
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Audrey Shillington,
MSW ’87, PhD ’87,
GM ’93, director of the
School of Social Work at
Colorado State University
since 2012, also is
assuming responsibilities
as the associate dean
for academic affairs in the College of
Health and Human Sciences. Additionally,
she is professor of epidemiology at the
Colorado School of Public Health. She has

published in the areas of psychometrics,
epidemiology, prevention and intervention
work aimed at adolescent and young adult
risk behaviors. She has been principal
investigator and co-investigator on National
Institutes of Health, National Institute on
Drug Abuse, National Institute on Alcohol
Abuse and Alcoholism state grants totaling
more than $14 million. Her current work
is focused on intervention and prevention
efforts related to the changing landscape in
legalized recreational marijuana use.

Frank Puc, PT ’94,
was named CEO at
Revolution Physical
Therapy Weight Loss
based in the greater
Chicago area.
Imran Zoberi, MD ’96, HS ’01, is a
professor of radiation oncology at the
School of Medicine, chief of the breast
cancer service and chief of hyperthermia
service in radiation oncology and serves as
clinical director for radiation oncology at
Barnes-Jewish West County Hospital.
Dawn Ebach, MD
’98, was promoted
to clinical professor
at the University of
Iowa Carver College
of Medicine July 1,
2017. She is a pediatric
gastroenterologist in the
Stead Family Department of Pediatrics.

2000 S
Kristin Will, OT ’14, plays with children in a small Ugandan village.

Will helps establish Ugandan
occupational therapy clinic

O

ccupational therapy alumna Kristin Will, OT ’14, is transitioning from
providing clinical care in the U.S. to working alongside the Musana
Community Development Organization to start an occupational therapy clinic
and outreach program in Iganga, a town in the eastern region of Uganda. Will
plans to collaborate with Musana over a 15-month period to expand services
in a health center and bridge social and medical projects.
Musana’s mission is to provide the community with locally owned and
operated sustainability projects, including schools, business loans, farming
and social work. The organization has been working in the Ugandan community
of Iganga for more than nine years.
From an early age, Will’s parents exposed her to the need for international aid,
and in high school she traveled to Kenya to assist with a medical education team.
“I knew that I wanted to work internationally ever since,” she said.
During her time at the School of Medicine, Will sought to use her training and
skills to better understand the many internal and external factors that influence a
person’s life, from cognition and physical state to social capital and cultural influences.
“I am excited to use the skills and knowledge that occupational therapy has given
me to better understand the people in developing communities and to work together
with them to bring sustainable development to their communities,” Will said.
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Julie K. Schwarz, MD ’04, PhD ’04, HS,
has been named director of the Cancer
Biology Division in the Department of
Radiation Oncology at WUSM.
Joel C. Geerling, MD
’08, PhD ’08, is an
assistant professor
of neurology at the
University of Iowa
Hospital and Clinics.
Rahul Kasukurthi,
MD ’10, GM ’10, looks forward to
beginning his first post-fellowship
attending job in plastic surgery at
Kaiser Permanente in Portland, Ore.

2010 S
Aaron Norris, MD ’12, PhD ’12, was
selected to receive a Foundation for
Anesthesia Education and Research
(FAER) Mentored Research Training Grant.
The grant is a two-year faculty award to
“help anesthesiologists develop the skills,
preliminary data for subsequent grant
applications and research publications
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needed to become independent
investigators.” Norris received the FAER
grant for his project titled “Isoflurane
Activated Neural Circuits,” which will
examine the functional relationship
between neurons activated by isoflurane
and neurons active during sleep.

Rogers pens
science thrillers

C

ombining her
passions for
microbiology and
literature, alumna
Amy Rogers, MD/
PhD ’99, now writes
and publishes science
thrillers. A trainee
of the Medical Scientist Training
Program, Rogers initially assumed
she would work as a research
scientist. As she began teaching
undergraduate microbiology
and molecular biology courses at
California State University in the mid
2000s, Rogers found that she was
“bursting with story ideas.”
Acknowledging that she didn’t
know how to write fiction, Rogers
began by writing critical reviews of
any science thriller novels that she
could find and launching a website,
ScienceThrillers.com. Now, she is
author of three published novels:
“Petroplague,” her debut book,
“Reversion” and “The Han Agent.”
“My goal with the science is
to make it entirely plausible and
accessible to the non-technical
reader, while also keeping it as
accurate as the story allows,” Rogers
said. All of her books feature
interesting microbes, a female
scientist as the protagonist, and
at least one lab experiment that
plays a critical plot role.
More information can be
found at ScienceThrillers.com
and AmyRogers.com.
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Amit Patel, MD
’12, HS ’13, and
Ami Patel, MD ’12,
HS ’15, proudly
announce the birth
of their son, Avi
Amit Patel, born
on Aug. 4, 2017.
Lora Melman, LA
’98, HS ’13, is a
fellowship-trained,
board-certified and da
Vinci robot-certified
specialist surgeon
in New Jersey who
is focused on providing cutting-edge
surgical care by combining enhanced
recovery methods with minimal-access
techniques. She feels fortunate to have
trained with prominent leaders in hernia,
bariatrics and foregut surgery and her
specific areas of interest include surgical
weight loss for obesity, repair of all
types of abdominal wall hernias, sport
hernias, repair of diaphragmatic and
hiatal hernias, treatment of esophageal
dysmotility disorders, reflux disease
and minimal-access adrenalectomy
and splenectomy. Melman, an expert
in the realm of hernia repair, is a widely
published author of peer-reviewed
literature on hernia repair biomaterials.
Yi Wang, MD ’13, began working
as a general pediatrician at Legacy
Community Health in Houston.
Stephanie Weyrauch,
GM ’15, DPT ’15,
recently held a legislative
day at her private practice,
RehabAuthority Physical
Therapy in Thief River
Falls, Minn. The staff
welcomed Minnesota Congressman Collin
Peterson while the team advocated for
several issues, including physical therapy
as an alternative to opioids for treatment of
chronic pain, increased access to physical
therapy services in rural areas, and repeal
of the Medicare Therapy Cap. Local news
reporters also attended and captured
video on how physical therapy has helped
some of Weyrauch’s patients wean off
opioids and live a more fulfilling life.

Jeffrey Fletcher Moley, MD, a
highly regarded professor of
surgery, chief of the Section
of Endocrine and Oncologic
Surgery and associate director
at Siteman Cancer Center at
Barnes-Jewish Hospital and
Washington University School
of Medicine, died Sunday,
Oct. 15, 2017, at his home in
Kirkwood following a sudden
cardiac event. He was 64.
He had been married for 30 years to
Kelle H. Moley, MD, the James P. Crane
Professor of Obstetrics and Gynecology.
For more than two decades, Moley was a
pioneer in researching and treating Multiple
Endocrine Neoplasia (MEN), rare inherited
syndromes that often cause an aggressive
form of thyroid cancer and other endocrine
diseases, particularly in those at young ages.
Moley was part of a team that identified
the genetic mutations responsible for MEN
syndromes and advanced a preventive
procedure that includes surgical removal of
the thyroid gland. Moley also operated on
patients with recurrent thyroid cancer and
other endocrine diseases.
“Jeff was a masterful surgeon,” said
Timothy J. Eberlein, MD, the Spencer T. and
Ann W. Olin Distinguished Professor, head of
the Department of Surgery, director of
Siteman Cancer Center and surgeon-in-chief
at Barnes-Jewish Hospital. “He delicately
performed surgery to remove the thyroid
gland in young children — some only a few
months old — who were destined to develop
an inherited form of thyroid cancer. The
margin of error in these procedures is almost
none, and Jeff was simply remarkable.”
Besides treating patients at Barnes-Jewish
and St. Louis Children’s hospitals, Moley
worked for more than three decades for the
VA St. Louis Health Care System. At each of
the hospitals, Moley helped train residents
and medical students.
In addition to his wife, Moley is survived
by: three sons, Patrick, Charles and John; his
mother, Janis Walton Moley; a sister, Janis
McCarthy; and a brother, Roger Moley.
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Emerson Chairman Emeritus Charles F. Knight, a major benefactor
of Washington University and longtime member of its Board of
Trustees, died Tuesday, Sept. 12, 2017, of complications from
Alzheimer’s disease at Missouri Baptist Medical Center. He was 81.
Knight, who was chief executive officer at Emerson Electric
Co. for 27 years, helped shape the present-day Washington
University, according to Chancellor Mark S. Wrighton.
“Chuck Knight was a loyal and dedicated friend of Washington
University for more than 40 years. His extraordinary generosity,
support and vision can be felt and seen throughout our
campuses,” Wrighton said.
“He, along with his wife, Joanne, showed an unwavering commitment to advancing
the university as well as the St. Louis community. Whether through helping establish Olin
Business School as one of the premier institutions of business education and research in
the world, or his critical support in building the Alvin J. Siteman Cancer Center into the
country’s third-largest cancer center, Chuck was dedicated to supporting institutions that
improve lives and advance knowledge,” he added.
A deep commitment to supporting medical research drove his support for the School
of Medicine, where he had served on its National Council.
He and his wife established the Charles F. and Joanne Knight Distinguished Professorship
in Orthopaedic Surgery, providing top-level teaching and research in this growing area.
The Joanne Knight Breast Health Center and Breast Cancer Program were dedicated in
April 2007 in appreciation of the generosity and leadership of the Knights in supporting
advancements in breast cancer research, patient care and community outreach at the
Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine.
The Knights, longtime leaders in supporting Alzheimer’s disease research, made a
major commitment to the School of Medicine to advance Alzheimer’s research. The
university recognized the couple in 2010 by naming its world-renowned Alzheimer’s
Disease Research Center in their honor.
He served in a number of leadership capacities for Barnes Hospital, overseeing the
creation of Barnes-Jewish Hospital and helping engineer the formation of BJC Health
System, now known as BJC HealthCare.
He served as board chairman of the BJC system in the 1990s and was named emeritus
chairman for life of Barnes-Jewish Hospital.
In 2002, Barnes-Jewish Hospital opened the Charles F. Knight Emergency and Trauma
Center, a 52,000-square-foot facility offering 61 beds and a comprehensive environment
for specialized care.
In addition to his wife, he is survived by children Lester Knight of Chicago, Anne
Knight Davidson of St. Louis, Steven Knight of Seattle and Jennifer Knight Beckmann of
Chicago; 12 grandchildren; and three great-grandchildren.

1930 S

Denise Thomas, a medical assistant for 28 years in the Division
of Hematology, died July 4, 2017, in St. Louis. Thomas, 52, died
several days after suffering a stroke at her home.
Thomas was on track to earn a bachelor’s degree in healthcare management from University College in December. The
college plans to award her degree posthumously.
Thomas is survived by her husband, Theo Thomas; her
sons, Cory J., Phillip A. and Andrew A. Thomas; her sister,
Vinissa Thomas; her
brothers, Norval L.
For full obituaries, visit:
Washington, Milton Bell,
wumcnews.org/obits
Lamont Thomas and Frank P. Thomas; and six
grandchildren.

1970 S
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Yvonne Bost Pickett, NU ‘38; Aug. ‘17

1940 S
Ralph Berg Jr., MD ‘45; June ‘17
Juanita G. Brownback, NU ‘48; Aug. ‘17
J. Richard Compton, LA ‘40, MD ‘43; Aug. ‘17
Richard A. Jones, MD ‘43; Aug. ‘17
Jean J. Norwood, NU ‘43; Aug. ‘17
Irene M.C. Restad, OT ‘48; June ‘17
Harold Speert, HS ‘42; Feb. ‘17
William B. Stocker, DE ‘46; Aug. ‘17

1950 S
Edwin E. Carter, MD ‘54; July ‘17
Rudolph E. Catanzaro, LA ‘49, MD ‘50; Aug. ‘17
Richard L. Ellis, DE ‘51; Aug. ‘17
William Y. Eubank, MD ‘53; July ‘17
Nancy Ferreira, OT ‘56; March ‘17
Ann Feldman Freeman, PT ‘59; Aug. ‘17
Guy T. Gillespie Jr., HS ‘54; June ‘17
Bill L. Hamilton, HA ‘56; Feb. ‘17
John W. Hard, LA ‘50, MD ‘54; Sept. ‘17
Bertram W. Justus, MD ‘57; May ‘17
M. Richard Katz, LA ‘52, MD ‘55; June ‘17
Leslie E. Long, DE ‘57; Sept. ‘17
Roy A. Nelson Jr., DE ‘57; Feb. ‘17
Havner H. Parish Jr., MD ‘56; June ‘17
Gonzalo T. Roman Jr., HS ‘59; Aug. ‘17
Paul A. Rubenstein, MD ‘57; July ‘17
Sidney L. Saltzstein, HS ‘58; May ‘17
Semon J. Sandven, MD ‘51; July ‘17
Jack C. Tippett, LA ‘49, MD ‘53; Aug. ‘17
Earl J. Wipfler Jr., LA ‘52, MD ‘55; Aug. ‘17

1960 S
Martha Anne Coleman, GN ‘65; Apr. ‘17
Susan Hackman Kingston, NU ‘67; Sept. ‘17
Anne P. Lanier, MD ‘66; May ‘17
Robert T. Miller, MD ‘63; March ‘17
Paul M. Packman, LA ‘59, MD ‘63; Sept. ‘17
Symuel H. Smith, UC ‘61, HA ‘65; June ‘17

Richard Lewis Baron, MD ‘76; May ‘17
Jaswinder Kaur Ghuman, HS ‘79; Aug. ‘17
Pamela A. Pedersen, GR ‘71; Aug. ‘17
Robert Dale Rounds, DE ‘74; March ‘17
Thomas P. Wharton Jr., MD ‘71; April ‘17

1980 S
Jeanne Dahlen Lewis, MD ‘82; May ‘17
Richard Marias, DE ‘84; Aug. ‘17

1990 S
Pamela Jo Smith, OT ‘92; June ‘17
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James Wittmer in his many roles (clockwise from left): on a congressional trip to Cairo in 1975; with an aero club Cessna 150 in 1962;
caring for a hurricane evacuee on a rescue helicopter in 1968; and in pressure suit training at a simulated altitude of 68,000 feet in 1962.

Flight surgeon’s storied career
S
BY CHANNING SUHL

tanding in the cornfields near his
Carlinville, Illinois home, a young James
Wittmer, MD ’57, MPH, watched in
amazement as planes flew overhead.
A lifelong curiosity about the world around
him — along with extraordinary leadership abilities
— drove Wittmer to work on
“Washington
some of NASA’s first human
University
spaceflight programs, to
opened up the
lead Vietnam War triage
world to me.”
operations, to travel the globe
as an attending physician on
congressional trips, and to
direct health and safety in
top U.S. corporations.
“Even as a child, I knew
there was so much out there
in the world, and I needed to
see it and do it all,” Wittmer said. “Washington
University opened up the world to me — the one
I’d only read about.”
Wittmer, a retired colonel, attended undergraduate classes at Washington University and
earned a medical degree from its School of
Medicine. He and his wife, Juanita, an accomplished
artist, are parents to three grown daughters and
live in Texas. Recently, the couple committed
estate gifts to fund professorships and scholarships
on both campuses — supporting personalized
medicine initiatives at the School of Medicine and
the Driving Discovery project in Arts & Sciences.

outlook.wustl.edu

As an undergraduate, Wittmer excelled in and
out of the classroom, participating in intramural
sports and Thurtene Honorary. During his medical
school admission interview, he met C. Barber
Mueller, MD, an educator and surgeon who had
grown up on the same Carlinville street. Mueller
became a valued mentor to Wittmer.
Following a surgical internship at the
University of Virginia Hospital in 1958, Wittmer
was drafted. He served two years as a U.S. Air
Force flight surgeon and completed the USAF
Aerospace Medicine Specialty Training Program.
The first year of this training involved earning
a master’s degree in public health from Harvard
University. He remembers being “swept up” in
the country’s space flight intrigue post-Sputnik.
Wittmer has the distinction of working on
NASA’s second human spaceflight program, Project
Gemini, from 1965-67. In this pre-satellite era,
NASA relied on crews deployed to ships around the
world for real-time assessment of the astronauts.
Wittmer had minutes to check astronauts’
vital signs and physiological responses as their
spacecraft passed overhead and relay that data to
Mission Control Center in Houston. He did this
by monitoring a console that received information
from electrodes attached to the astronauts’ bodies.
After a 21-year Air Force career, Wittmer
moved to New York, spending two years as U.S.
medical director for Mobil Oil Corporation and
12 years with ITT Corporation, rising to corporate
vice president for health, environment and safety.
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